CN103930098B - 含有芬太尼及其同族体的经皮吸收制剂 - Google Patents
含有芬太尼及其同族体的经皮吸收制剂 Download PDFInfo
- Publication number
- CN103930098B CN103930098B CN201280055976.8A CN201280055976A CN103930098B CN 103930098 B CN103930098 B CN 103930098B CN 201280055976 A CN201280055976 A CN 201280055976A CN 103930098 B CN103930098 B CN 103930098B
- Authority
- CN
- China
- Prior art keywords
- medicine
- acrylic acid
- adhesion coating
- transdermal formulation
- series sticker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Abstract
Description
Claims (13)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20110095787 | 2011-09-22 | ||
KR10-2011-0095787 | 2011-09-22 | ||
KR10-2012-0105181 | 2012-09-21 | ||
KR1020120105181A KR101438728B1 (ko) | 2011-09-22 | 2012-09-21 | 펜타닐 및 이의 동족체를 함유하는 경피 흡수성 제제 |
PCT/KR2012/007599 WO2013042989A1 (ko) | 2011-09-22 | 2012-09-21 | 펜타닐 및 이의 동족체를 함유하는 경피 흡수성 제제 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103930098A CN103930098A (zh) | 2014-07-16 |
CN103930098B true CN103930098B (zh) | 2017-06-06 |
Family
ID=48435180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280055976.8A Active CN103930098B (zh) | 2011-09-22 | 2012-09-21 | 含有芬太尼及其同族体的经皮吸收制剂 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20140243765A1 (zh) |
EP (1) | EP2759294B1 (zh) |
KR (1) | KR101438728B1 (zh) |
CN (1) | CN103930098B (zh) |
WO (1) | WO2013042989A1 (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140243765A1 (en) | 2011-09-22 | 2014-08-28 | Samyang Biopharmaceuticals Corporation | Percutaneously absorbable preparation containing fentanyl and homologue thereof |
CN103705492A (zh) * | 2012-09-28 | 2014-04-09 | 日东电工株式会社 | 含有氧化胺的贴剂制剂 |
GB201317718D0 (en) * | 2013-10-07 | 2013-11-20 | Buzzz Pharmaceuticals Ltd | Novel formulation |
EP2921184A1 (de) | 2014-03-19 | 2015-09-23 | LTS LOHMANN Therapie-Systeme AG | Überpflaster mit verbesserter Verträglichkeit und einer langen Haftungsdauer und Verfahren zu seiner Herstellung |
JP6940407B2 (ja) * | 2014-12-19 | 2021-09-29 | キンデーバ ドラッグ デリバリー リミティド パートナーシップ | フェンタニルを含む経皮薬物送達デバイス |
WO2016149077A2 (en) * | 2015-03-13 | 2016-09-22 | Amneal Pharmaceuticals Llc | Fentanyl transdermal delivery system |
US20170291020A1 (en) * | 2016-04-12 | 2017-10-12 | Mylan Inc. | Double disk transdermal system |
US9650338B1 (en) | 2016-07-29 | 2017-05-16 | VDM Biochemicals, Inc. | Opioid antagonist compounds and methods of making and using |
CN107684552B (zh) * | 2016-12-12 | 2020-06-23 | 安徽天耘医疗器械有限公司 | 一种依托芬那酯贴剂 |
EP4071108A1 (en) | 2017-04-18 | 2022-10-12 | Breakthrough Technologies, LLC | Sulfur production |
CN107233333A (zh) * | 2017-06-12 | 2017-10-10 | 重庆安格龙翔医药科技有限公司 | 一种盐酸依匹斯汀透皮贴剂及其制备方法 |
KR102115303B1 (ko) * | 2018-08-16 | 2020-05-26 | 고세윤 | 체온감응형 점착시트용 화장료 조성물 및 이를 이용한 점착시트. |
CN110013602B (zh) * | 2019-04-17 | 2021-10-26 | 杨高云 | 用于治疗肢端型白癜风的手套及其制备方法 |
CN112823793A (zh) * | 2019-11-20 | 2021-05-21 | 成都康弘药业集团股份有限公司 | 一种含有多奈哌齐的透皮贴剂及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1193275A (zh) * | 1996-05-13 | 1998-09-16 | 久光制药株式会社 | 含芬太尼的透皮给药胶带制剂 |
CN1378471A (zh) * | 1999-10-11 | 2002-11-06 | 株式会社三养社 | 双重粘合剂经皮药物释放系统 |
CN1535142A (zh) * | 2001-03-16 | 2004-10-06 | 施用芬太尼的经皮贴剂 | |
CN1713899A (zh) * | 2001-08-24 | 2005-12-28 | Lts勒曼治疗系统股份公司 | 含有芬太尼或其相关物质的透皮治疗体系 |
CN1909892A (zh) * | 2003-10-30 | 2007-02-07 | 阿尔扎公司 | 具有降低的滥用可能性的透皮止痛剂系统 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588580B2 (en) | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
US5186939A (en) | 1987-04-23 | 1993-02-16 | Cygnus Therapeutic Systems | Laminated composite for transdermal administration of fentanyl |
US7063859B1 (en) | 1999-04-28 | 2006-06-20 | Noven Pharmaceuticals, Inc. | Barrier film lined backing layer composition and method for topical administration of active agents |
CA2384679A1 (en) * | 1999-09-08 | 2001-03-15 | Srinivasan Venkateshwaran | Using quaternary ammonium salts for transdermal drug delivery |
US20020119187A1 (en) * | 2000-09-29 | 2002-08-29 | Cantor Adam S. | Composition for the transdermal delivery of fentanyl |
KR100844312B1 (ko) * | 2001-09-06 | 2008-07-07 | 노사케미컬(주) | 펜타닐 경피 투여 제제 |
US6893655B2 (en) | 2001-10-09 | 2005-05-17 | 3M Innovative Properties Co. | Transdermal delivery devices |
WO2005009510A2 (en) | 2003-07-23 | 2005-02-03 | The Regents Of The University Of California | Penetration enhancer combinations for transdermal delivery |
KR100563194B1 (ko) * | 2003-11-14 | 2006-03-21 | (주) 에프디엘 | 펜타닐을 유효성분으로 함유하는 경피투여제제 |
KR100682729B1 (ko) * | 2004-06-15 | 2007-02-15 | (주)아모레퍼시픽 | 신규 경피흡수제제 및 그 제조방법 |
WO2006041907A2 (en) * | 2004-10-08 | 2006-04-20 | Noven Pharmaceuticals, Inc. | Transdermal delivery of estradiol |
KR100663163B1 (ko) | 2005-10-24 | 2007-01-02 | (주)아모레퍼시픽 | 비스테로이드성 소염진통제를 함유하는 경피 투여 제제 |
CA2692884C (en) * | 2007-07-10 | 2016-09-20 | Agile Therapeutics, Inc. | Dermal delivery device with in situ seal |
US20140243765A1 (en) | 2011-09-22 | 2014-08-28 | Samyang Biopharmaceuticals Corporation | Percutaneously absorbable preparation containing fentanyl and homologue thereof |
-
2012
- 2012-09-21 US US14/346,031 patent/US20140243765A1/en not_active Abandoned
- 2012-09-21 WO PCT/KR2012/007599 patent/WO2013042989A1/ko active Application Filing
- 2012-09-21 KR KR1020120105181A patent/KR101438728B1/ko active IP Right Grant
- 2012-09-21 CN CN201280055976.8A patent/CN103930098B/zh active Active
- 2012-09-21 EP EP12833553.6A patent/EP2759294B1/en not_active Revoked
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1193275A (zh) * | 1996-05-13 | 1998-09-16 | 久光制药株式会社 | 含芬太尼的透皮给药胶带制剂 |
CN1378471A (zh) * | 1999-10-11 | 2002-11-06 | 株式会社三养社 | 双重粘合剂经皮药物释放系统 |
CN1535142A (zh) * | 2001-03-16 | 2004-10-06 | 施用芬太尼的经皮贴剂 | |
CN1713899A (zh) * | 2001-08-24 | 2005-12-28 | Lts勒曼治疗系统股份公司 | 含有芬太尼或其相关物质的透皮治疗体系 |
CN1909892A (zh) * | 2003-10-30 | 2007-02-07 | 阿尔扎公司 | 具有降低的滥用可能性的透皮止痛剂系统 |
Also Published As
Publication number | Publication date |
---|---|
EP2759294A4 (en) | 2015-04-22 |
EP2759294A1 (en) | 2014-07-30 |
KR101438728B1 (ko) | 2014-09-05 |
KR20130032271A (ko) | 2013-04-01 |
US20140243765A1 (en) | 2014-08-28 |
WO2013042989A1 (ko) | 2013-03-28 |
CN103930098A (zh) | 2014-07-16 |
EP2759294B1 (en) | 2017-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103930098B (zh) | 含有芬太尼及其同族体的经皮吸收制剂 | |
CA2670290C (en) | Transdermal therapeutic system for administering the active substance buprenorphine | |
EP2687205B1 (en) | Fentanyl transdermal patch | |
WO2004019988A1 (ja) | 貼付剤 | |
CA2671636A1 (en) | Pharmaceutical composition for external application and adhesive skin patch | |
PL175083B1 (pl) | Przezskórny układ terapeutyczny do podawania galantaminy na skórę | |
EP1847264B1 (en) | Bisoprolol patch | |
EP2298352B1 (en) | Percutaneous absorption enhancer and transdermal preparation using the same | |
WO2003022270A1 (en) | Transdermal administration of an enalapril ester | |
CA3162229A1 (en) | Transdermal therapeutic system containing agomelatine | |
JP6729584B2 (ja) | 経皮吸収型貼付剤 | |
EP3100733B1 (en) | Emedastine-containing tape | |
EP3616699B1 (en) | Adhesive patch | |
JP6695571B2 (ja) | 経皮吸収型製剤 | |
KR101353478B1 (ko) | 펜타닐을 함유하는 경피투여용 패취 제제 | |
US20050100589A1 (en) | Transdermal administration of ace inhibitors | |
JP6512905B2 (ja) | フェンタニル含有貼付剤 | |
US20180318232A1 (en) | Formulation for percutaneous administration containing fentanyl and analogue thereof | |
AU2002332544A1 (en) | Transdermal administration of an enalapril ester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170509 Address after: Seoul special city Applicant after: Samyang Biopharmaceuticals Corporation Address before: Seoul special city Applicant before: Transderm Inc Applicant before: Samyang Biopharmaceuticals Corporation |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210813 Address after: Seoul City, Korea Patentee after: Sanyang holding Co. Address before: Seoul special city Patentee before: SAMYANG BIOPHARMACEUTICALS Corp. |